Cyclerion Therapeutics (CYCN) 10% owner Slate Path Capital bought 961,538 shares for $3M at $3.12
Insider transactions reported
Slate Path Capital LP (10% owner at Cyclerion Therapeutics Inc., CYCN) reported that they bought 961,538 shares for $3M at $3.12 on Jun 3, 2021. After these transactions the filing shows 7,157,601 shares held indirectly (See footnote).
- Reporting person
- Slate Path Capital LP
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 3, 2021 | Open-market purchase (P) | Common Stock, no par value1 | +961,538 | $3.12 | $3M | 7,157,601 indirect |
Holdings before and after
- Common Stock, no par value: 6,196,063 to 7,157,601 indirect, See footnote
Footnotes from the filing
- 1. The securities to which this filing relates are held by Slate Path Master Fund LP (the Master Fund ), a Cayman Islands exempted limited partnership. Slate Path Capital LP (the Investment Manager ), a Delaware limited partnership acts as the investment manager of the Master Fund. Mr. David Greenspan serves as the managing member of Jades GP, LLC, a Delaware limited liability company and the general partner of the Investment Manager. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Slate Path Capital report in this CYCN Form 4?
Slate Path Capital LP (10% owner at Cyclerion Therapeutics Inc., CYCN) reported that they bought 961,538 shares for $3M at $3.12 on Jun 3, 2021. After these transactions the filing shows 7,157,601 shares held indirectly (See footnote).
How many CYCN shares does Slate Path Capital hold after this filing?
The filing shows 7,157,601 shares held indirectly (See footnote) after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for CYCN
Earlier insider filings at CYCN
- May 10, 2021SEC Form 4: Hecht Peter M bought $733,860 worth of Common Stock (302,000 units at $2.43), increasing direct ownership by 33% to 1,224,528 units
- May 7, 2021SEC Form 4: Hecht Peter M bought $1,693,943 worth of Common Stock (698,001 units at $2.43), increasing direct ownership by 311% to 922,528 units
- Mar 1, 2021SEC Form 4: Anjeza Gjino sold $7,296 worth of Common Stock (1,824 units at $4.00), decreasing ownership by 5% to 31,599 units
- Mar 1, 2021SEC Form 4: I Christopher Wright sold $10,522 worth of Common Stock (2,637 units at $3.99), decreasing ownership by 6% to 42,728 units
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow CYCN and get a push notification the moment its next story breaks.